It looks like you're not logged in. Conference access is restricted to registered users.
Please log into your profile to access the course.
38th Annual Calgary Therapeutics Course
Attend a keynote, short snapper, or panel discussion.
12:50 – 13:00 | Opening Remarks
13:00 – 13:35 | COVID-19 Vaccination (Jenne)
13:35 – 13:55 | Trends in Addiction Medicine: Naltrexone – Evidence for Use and Opportunities (Ghosh)
13:55 – 14:15 | Update on Shingles and Pneumococcal Vaccines – Which to Choose and Why (Hughes)
14:25 – 14:45 | Natural Health Products Used for Cognition and Their Drug Interactions (Ho)
14:45 – 15:05 | Vaccine Hesitancy – Patient Concerns and Approach to Address Them (Constantinescu)
15:05 – 15:25 | Practical Approaches to Deprescribing Proton Pump Inhibitors (PPIs) (Van Zanten)
16:40 – 17:30 | New Hats in the Pandemic (Austin, Nguyen, Karr, Sadowski)
Attend a workshop or breakout room session.
Workshop 1 15:40
Case Based Practical Approaches to Deprescribing PPIs (Scheelar, van Zanten, Greenaway)
Workshop 2 15:40
Applying an Approach to Vaccine Hesitancy (Constantinescu)
Workshop 3 15:40
Non-drug Treatments are more Efficacious for Reducing Symptoms of Agitation in Persons with Dementia (Goodarzi, Watt)
Workshop 4 15:40
Update on Psoriasis and Risks and Benefits of Onychomycosis Treatment (Traboulsi)
Learn more about the speakers presenting at the 38th Annual Calgary Therapeutics Conference
Affiliations: Course Chair; Clinical Associate Professor, Dept. of Medicine, Cumming School of Medicine, University of Calgary; Specialist in Internal Medicine, Alberta Health Services, Calgary Zone
Bio: Dr. Barry Baylis graduated from the University of Calgary Medical School in 1983. He completed a post-graduate fellowship in Internal Medicine and in addition did a two-year fellowship in Endocrinology and Metabolism. He joined the faculty at the University of Calgary and the Foothills Medical Centre (FMC) in December 1989 as a founding member of the Division of General Internal Medicine. From 1989 onward he has contributed to undergraduate medical education, post-graduate medical education, and continuing medical education. He is also actively contributing to and has participated in clinical trials research at the FMC since 1990.
As one of the founding leaders of the Ward of the 21st Century (W21C), Dr. Baylis has been very active in fundraising for the initiative and has been heavily involved in its strategic direction as a member of its Executive Committee in his continued roll as a leader of the W21C.
Robin Scheelar, BSc BPharm APA
Affiliations: Drug Utilization & Stewardship Pharmacist, Alberta Health Services
Bio: Robin has worked as a clinical hospital pharmacist primarily in intensive care and geriatrics for the past 20 years. Recently, Robin transitioned to the role of Drug Utilization and Stewardship pharmacist with Alberta Health Services and has been working in collaboration with the Digestive Health Strategic Care Network to improve prescribing practices of PPIs across Alberta.